TrialJCO precision oncology2021

Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial.

Alice P Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.